The Pox Virion Molecular Interactome
The Pox Virion Molecular Interactome
批准号:
8731174
负责人:
Paul D Gershon
金额:
$19.31万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-09 至 2015-08-31
关键词:
AfricaAgricultureAnimalsAntibodiesAntiviral AgentsAppearanceApplications GrantsArchitectureAreaBindingBoxingCapsid ProteinsComplementComplexCore ProteinDNA BindingDevelopmentDiseaseDisease OutbreaksEnzymesEquipment and supply inventoriesFamilyFamily PicornaviridaeFutureGenetic TranscriptionGenomeHerpesviridaeHeterogeneityHumanIn SituInterventionKnowledgeLateralMass Spectrum AnalysisMediatingMedicalMethodologyMolecularMolecular StructureMonkeypoxNormal Pressure HydrocephalusNuclear Pore ComplexNucleoproteinsNucleosomesPeptidesPositioning AttributePoxviridaeProteinsRNA Polymerase IIRNA VirusesResolutionRiskRoleRouteShapesSmallpoxSolubilityStagingStructural ProteinStructureTechniquesTestingTextilesTherapeuticTherapeutic AgentsVacciniaVacciniumVirionVirusVirus DiseasesYeastsanthrax lethal factorbasecrosslinkdesignmulticatalytic endopeptidase complexnovelparticleprotein complexprotein crosslinkprotein protein interactionpublic health relevancetherapeutic vaccinetooltransmission processvirus envelopeyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Smallpox has, historically, been one of the great killers of mankind. Although this disease is considered to have been eradicated some 35 years ago, the poxviruses, nonetheless, comprise a major family of viruses of medical, ecological and agricultural importance. For humans, aside from the possibility of smallpox re-introduction, eradication has coincided with the appearance of human monkeypox in Africa during the past 40 years and in the US during the past decade. Not knowing the lethal factor in smallpox, the full potential of such outbreaks remains uncertain. The importance of virus envelopes and capsid proteins in mediating the effects of antiviral therapeutics and vaccines is undisputed. From the picornaviruses to the herpesviruses, an understanding of virion outer molecular structures at molecular or atomic resolution, has instructed the rational design of therapeutic agents and an understanding of mechanisms that cause and thwart virus infection and disease. Due to their complexity, asymmetry and heterogeneity, the poxviruses have, however, been particularly persistent in defeating attempts to understand their virion structure at the molecular
level, thus evading an important potential avenue for intervention. The P.I. hypothesizes that the complexity of the vaccinia virion may prove to be an Achilles heel. In addition, a full understanding of virion structure may be regarded as one of the last remaining black boxes in the lifecycle of the poxviruses - one which impinges upon the early transcription, genome uncoating and virion assembly stages of poxvirus replication. The major hole in our knowledge of pox virion structure lies at a level between the inventory of proteins present within the virion
(which is largely known) and the basic topological and topographical features of the intact particle (also known). This intervening area may be referred to as the virion's "molecular architecture", or protein "interactome". In this R21 proposal, the P.I. has chosen a protein-protein crosslinking approach in combination with mass spectrometry. Such an approach for interactome analysis is unbiased in many respects, and has a track record of informing the molecular architectures of elaborate cellular assemblies such as the nuclear pore complex, 20S proteasome and RNA polymerase II. Aim 1 of this proposal seeks to identify directly juxtaposed proteins within the virion core via covalent protein-protein crosslinking/MS, taking "top-down" (protein-level) and "bottom-up" (peptide-level) approaches. The P.I. hypothesizes that the pox virion core wall may not be fundamentally dissimilar to the matrix protein layers of some enveloped RNA viruses, and that the classical delineation of enzymes in the deep interior with structural proteins surrounding may not be as clear cut as currently supposed.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Protein Primary Structure of the Vaccinia Virion at Increased Resolution.
痘苗病毒粒子的蛋白质一级结构的高分辨率。
DOI:
10.1128/jvi.01042-16
发表时间:
2016
期刊:
Journal of virology
影响因子:
5.4
作者:
[Ngo,Tuan, Mirzakhanyan,Yeva, Moussatche,Nissin, Gershon,PaulDavid]
通讯作者:
Gershon,PaulDavid
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells
-
批准号:10684733
-
项目类别:
-
资助金额:$46.57万
-
财政年份:2021
-
负责人:Paul D Gershon
-
依托单位:
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells
-
批准号:10443844
-
项目类别:
-
资助金额:$46.57万
-
财政年份:2021
-
负责人:Paul D Gershon
-
依托单位:
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells
-
批准号:10298555
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2021
-
负责人:Paul D Gershon
-
依托单位:
Molecular architecture of the Vaccinia virion by structural proteomics
-
批准号:10465049
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2019
-
负责人:Paul D Gershon
-
依托单位:
Molecular architecture of the Vaccinia virion by structural proteomics
-
批准号:10179428
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2019
-
负责人:Paul D Gershon
-
依托单位:
Molecular architecture of the Vaccinia virion by structural proteomics
-
批准号:10022126
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2019
-
负责人:Paul D Gershon
-
依托单位:
Novel nuclear and intracellular pathology in early AD
-
批准号:8702666
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2014
-
负责人:Paul D Gershon
-
依托单位:
The Pox Virion Molecular Interactome
-
批准号:8582931
-
项目类别:
-
资助金额:$21.73万
-
财政年份:2013
-
负责人:Paul D Gershon
-
依托单位:
LTQ Velos Pro mass spectrometer with ETD and other options
-
批准号:8447950
-
项目类别:
-
资助金额:$37.41万
-
财政年份:2013
-
负责人:Paul D Gershon
-
依托单位:
PROTEIN MASS SPECTROMETRY (SHARED RESOURCE)
-
批准号:7944552
-
项目类别:
-
资助金额:$2.14万
-
财政年份:2009
-
负责人:Paul D Gershon
-
依托单位:
MALDI TOF MASS SPECTROMETER
-
批准号:6292199
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2001
-
负责人:Paul D Gershon
-
依托单位:
PROTEIN MASS SPECTROMETRY (SHARED RESOURCE)
-
批准号:8740838
-
项目类别:
-
资助金额:$4.76万
-
财政年份:1997
-
负责人:Paul D Gershon
-
依托单位:
Mechanism of Poly(a) Tail Formation by Vaccinia Virus
-
批准号:6928609
-
项目类别:
-
资助金额:$27.45万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
Mechanism of Poly(a) Tail Formation by Vaccinia Virus
-
批准号:7267766
-
项目类别:
-
资助金额:$26.03万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
MECHANISM OF POLY(A) TAIL FORMATION BY VACCINIA VIRUS
-
批准号:2190762
-
项目类别:
-
资助金额:$16.28万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
MECHANISM OF POLYA TAIL FORMATION BY VACCINIA VIRUS
-
批准号:6331989
-
项目类别:
-
资助金额:$23.43万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
MECHANISM OF POLYA TAIL FORMATION BY VACCINIA VIRUS
-
批准号:2908994
-
项目类别:
-
资助金额:$24.76万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
MECHANISM OF POLY(A) TAIL FORMATION BY VACCINIA VIRUS
-
批准号:2459599
-
项目类别:
-
资助金额:$16.92万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
Mechanism of Poly(a) Tail Formation by Vaccinia Virus
-
批准号:6823030
-
项目类别:
-
资助金额:$27.3万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
MECHANISM OF POLYA TAIL FORMATION BY VACCINIA VIRUS
-
批准号:6496117
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1995
-
负责人:Paul D Gershon
-
依托单位:
海外基金